How to buy Applied Genetic stock (AGTC)

Applied Genetic is a biotechnology business based in the US. Applied Genetic shares (AGTC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.39 – the same closing value as a week prior. Applied Genetic employs 102 staff and has a trailing 12-month revenue of around $325,000.

Our top picks for where to buy Applied Genetic stock

Buy Applied Genetic stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Applied Genetic stock price (NASDAQ: AGTC)

Use our graph to track the performance of AGTC stocks over time.

Applied Genetic shares at a glance

• Key figures

Information last updated 2023-01-29.

Latest market close	$0.39
52-week range	$0.00 - $0.00
50-day moving average more info button	$0.35
200-day moving average more info button	$0.67
Wall St. target price	$0.34
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-1.46

Is it a good time to buy Applied Genetic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied Genetic price performance over time

Historical closes compared with the close of $0.3936 from 2022-12-09

1 week (2024-09-28)	N/A
1 month (2024-09-05)	N/A
3 months (2024-07-05)	N/A
6 months (2024-04-05)	N/A

1 year (2023-10-05)	N/A
2 years (2022-10-07)	43.18%
3 years (2021-10-05)	N/A
5 years (2019-10-09)	3.12

Applied Genetic financials

Revenue TTM	$325,000
Gross profit TTM	$-21,439,000
Return on assets TTM	-50%
Return on equity TTM	-161.14%
Profit margin	0%
Book value	$0.26
Market Capitalization more info button	$26.6 million

TTM: trailing 12 months

Applied Genetic share dividends

We're not expecting Applied Genetic to pay a dividend over the next 12 months.

Applied Genetic share price volatility

Over the last 12 months, Applied Genetic's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Genetic's is 1.5836. This would suggest that Applied Genetic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Applied Genetic overview

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc. ; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.

Frequently asked questions

null
What percentage of Applied Genetic is owned by insiders or institutions?
Currently 0.856% of Applied Genetic shares are held by insiders and 29.929% by institutions. How many people work for Applied Genetic?
Latest data suggests 102 work at Applied Genetic. When does the fiscal year end for Applied Genetic?
Applied Genetic's fiscal year ends in June. Where is Applied Genetic based?
Applied Genetic's address is: 14193 NW 119th Terrace, Alachua, FL, United States, 32615 What is Applied Genetic's ISIN number?
Applied Genetic's international securities identification number is: US03820J1007 What is Applied Genetic's CUSIP number?
Applied Genetic's Committee on Uniform Securities Identification Procedures number is: 03820J100